DanJamesFintelMD

PubMed

• 109 citations
  Comparative effectiveness of aspirin dosing in cardiovascular disease.
  W. Schuyler Jones, Hillary Mulder, Lisa M. Wruck, Michael J. Pencina, Sunil Kripalani, Daniel Muñoz, David L. Crenshaw, Mark B. Effron, Richard N. Re, Kamal Gupta, R. ...> ;The New England Journal of Medicine. 2021 May 15
• 5 citations
  Comparison of Metoprolol Versus Carvedilol After Acute Myocardial Infarction.
  Ghaith Zaatari, Dan J. Fintel, Haris Subacius, Joseph J Germano, Jacob Shani, Jeffrey J. Goldberger> ;The American Journal of Cardiology. 2021 May 15
• 52 citations
  Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial.
  Guillaume Marquis-Gravel, Matthew T. Roe, Holly Robertson, Robert A. Harrington, Michael J. Pencina, Lisa G. Berdan, Bradley G. Hammill, Madelaine Faulkner, Daniel Muñ...> ;JAMA Cardiology. 2020 May 1
• 22 citations
  Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.
  William Small, Jennifer L. James, Timothy D. Moore, Dan J. Fintel, Stephen Lutz, Benjamin Movsas, Mohan Suntharalingam, Yolanda I. Garces, Robert Ivker, John E. Moulde...> ;American Journal of Clinical Oncology. 2016 Apr 20
• 2 citations
  Comparison of Twelve-Lead Electrocardiogram Using a Glove-Based Recording System With Standard Methodology
  Michael Luc, Dan J. Fintel, Herman O. Klein, Roderick W. Childers, Victor Mor-Avi, Dan Tzivoni, Roberto M. Lang> ;The American Journal of Cardiology. 2013 Sep 15
• 44 citations
  2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery diseas...
  Christopher P. Cannon, Ralph G. Brindis, Bernard R. Chaitman, David J. Cohen, J. Thomas Cross, Joseph P. Drozda, Francis M. Fesmire, Dan J. Fintel, Gregg C. Fonarow, K...> ;Critical Pathways in Cardiology. 2013 Jun 1
• 142 citations
  2013 ACCF/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Acute Coronary Syndromes and Coronary Artery Disease
  Christopher P. Cannon, Ralph G. Brindis, Bernard R. Chaitman, David Cohen, J. Thomas Cross, Joseph P. Drozda, Francis M. Fesmire, Dan J. Fintel, Gregg C. Fonarow, Keit...> ;Circulation. 2013 Mar 5
• 75 citations
  2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery diseas...
  Christopher P Cannon, Ralph G Brindis, Bernard R Chaitman, David J Cohen, J Thomas Cross Jr, Joseph P Drozda Jr, Francis M Fesmire, Dan J Fintel, Gregg C Fonarow, Keit...> ;Journal of the American College of Cardiology. 2013 Mar 5
• 48 citations
  Organization and staffing practices in US cardiac intensive care units: a survey on behalf of the American Heart Association Writing Group on the Evolution of Critical...
  Ryan G. O'Malley, Benjamin A. Olenchock, Erin Bohula-May, Christopher Barnett, Dan J. Fintel, Christopher B. Granger, Jason N. Katz, Michael C. Kontos, Jeffrey T. Kuvi...> ;European Heart Journal. Acute Cardiovascular Care. 2013 Mar 1
• 178 citations
  Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models A Sc...
  David A. Morrow, James C. Fang, Dan J. Fintel, Christopher B. Granger, Jason N. Katz, Frederick G. Kushner, Jeffrey T. Kuvin, Jose Lopez-Sendon, Dorothea McAreavey, Br...> ;Circulation. 2012 Sep 11
• 30 citations
  Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options
  Dan J. Fintel> ;Vascular Health and Risk Management. 2012 Feb 15
• 18 citations
  Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary ang...
  Michael Tempelhof, Keith H. Benzuly, Dan J. Fintel, Marc Z. Krichavsky> ;Texas Heart Institute Journal. 2012 Jan 1
• 15 citations
  Early clopidogrel use in non-ST elevation acute coronary syndrome and subsequent coronary artery bypass grafting.
  Michael A. Burke, Richard T. Lee, Dan J. Fintel> ;American Heart Journal. 2011 May 1
• 40 citations
  Overweight and obesity: the pathogenesis of cardiometabolic risk.
  George A. Bray, Michael Clearfield, Dan J. Fintel, Donald S. Nelinson> ;Clinical Cornerstone. 2009 Jan 1
• 1 citations
  The role of RAS modification for primary and secondary stroke prevention.
  Dan J. Fintel> ;Postgraduate Medicine. 2009 Jul 1
• 29 citations
  Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardi...
  Deepu Alexander, Fang Shu Ou, Matthew T. Roe, Charles V. Pollack, E. Magnus Ohman, Christopher P. Cannon, W. Brian Gibler, Dan J. Fintel, Eric D. Peterson, David L. Brown> ;American Heart Journal. 2008 Sep 1
• 5 citations
  Antiplatelet Therapy in Cerebrovascular Disease: Implications of MATCH and CHARISMA Results for Cardiologists
  Dan James Fintel> ;Clinical Cardiology. 2007 Dec 1
• 2 citations
  Cardiologists use pulmonary artery catheter information to make homogenous treatment decisions.
  Manu Jain, Daya Upadhyay, Rajesh Balagani, Borko Jovanovic, Dan J. Fintel> ;Journal of Intensive Care Medicine. 2007 Sep 1
• 18 citations
  Reduced Mortality Rates after Intensive Statin Therapy in Managed-Care Patients
  Dan J. Fintel, Amie T. Joyce, Joan Mackell, Jennifer Graff, Erik Kuntze, Daniel A. Ollendorf> ;Value in Health. 2007 Mar 1
• 51 citations
  Insurance Coverage and Care of Patients with Non–ST-Segment Elevation Acute Coronary Syndromes
  James E. Calvin, Matthew T. Roe, Anita Y. Chen, Rajendra H. Mehta, Gerard X. Brogan, Elizabeth R. DeLong, Dan J. Fintel, W. Brian Gibler, E. Magnus Ohman, Sidney C. Sm...> ;Annals of Internal Medicine. 2006 Nov 21
• 138 citations
  Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
  Rajendra H. Mehta, Matthew T. Roe, Anita Y. Chen, Barbara L. Lytle, Charles V. Pollack, Ralph G. Brindis, Sidney C. Smith, Robert A. Harrington, Dan J. Fintel, Elizabe...> ;Archives of Internal Medicine. 2006 Oct 9
• 52 citations
  Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.
  Pierluigi Tricoci, Matthew T. Roe, Jyotsna Mulgund, L. Kristin Newby, Sidney C. Smith, Charles V. Pollack, Dan J. Fintel, Christopher P. Cannon, Deepak L. Bhatt, W. Br...> ;Archives of Internal Medicine. 2006 Apr 10
• 3 citations
  Dosing considerations and monitoring of low molecular weight heparins and glycoprotein IIb/IIIa antagonists in patients with renal insufficiency
  Chidambaram Rammohan, Dan J. Fintel> ;Current Cardiology Reports. 2003 Jul 1
• 18 citations
  Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization.
  Lee A. MacDonald, Sheridan N. Meyers, Dan J. Fintel, Neal Grosshans, Raffy Syegco, Charles J. Davidson> ;The Journal of Invasive Cardiology. 2003 Feb 1
• 2 citations
  From bench to bedside GP IIb–IIIa inhibitors
  Dan J. Fintel> ;Neurology. 2001 Sep 1
• Join now to see all

Journal Articles

• 2013 ACCF/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Acute Coronary Syndromes and Coronary Artery Diseas...  
  Cannon CP, Brindis RG, Chaitman BR, Cohen DJ, Cross JT Jr, Drozda JP Jr, Fesmire FM, Fintel DJ, Fonarow GC, Fox KA, Gray DT, Harrington RA, Hicks KA, Hollander JE, Kru..., Circulation, 1/1/2013
• Comparison of Twelve-Lead Electrocardiogram Using a Glove-Based Recording System With Standard Methodology  
  Luc M, Fintel DJ, Klein, H, Childers R, Mor-Avi V, Tzivoni D, Lang R, Am J Cardiol, 1/1/2013
• Thrombin-receptor antagonist vorapaxar in acute coronary syndromes  
  Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM..., N Eng J Med, 1/5/2012
• Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options  
  Fintel DJ, Vasc Health Risk Manag, 1/1/2012
• Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary ang...  
  Tempelhof MW, Benzuly, KH, Fintel DJ, Krichavsky, MZ, Tex Heart Inst J, 1/1/2012
• Evolution of critical care cardiology: transformation of the cardiovascular intensive care unit and the emerging need for new medical staffing and training models: a s...  
  Morrow DA, Fang JC, Fintel DJ, Granger CB, Katz JN, Kushner FG, Kuvin JT, Lopez-Sendon J, McAreavey D, Nallamothu B, Page RL 2nd, Parrillo JE, Peterson PN, Winkelman C..., Circulation, 1/1/2012
• Apixaban with antiplatelet therapy after acute coronary syndrome  
  Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansk..., N Engl J Med, 1/25/2011
• Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): A prespecified second...  
  Bakris GL, Sarafidis PA, Weir MR, Dahlof B, Pitt B, Jamerson K, Velazquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang TY, Weber MA; ACCOMPLISH Trial Investigators, Lancet, 1/3/2010
• Beta-Blocker use following myocardial infarction: Low prevalence of evidence-based dosing  
  Goldberger JJ, Bonow RO, Cuffe M, Dyer A, Rosenberg Y, O'Rouke R, Shah PK, Smith SC Jr; PACE-MI Investigators, Am Heart J, 1/1/2010
• Early versus delayed, provisional eptifibatide in acute coronary syndromes  
  Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van ‘t Hof A, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E, H..., N Eng J Med, 1/21/2009
• Ticagrelor versus clopidogrel in patients with acute coronary syndromes  
  Wallerntin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harring..., N Engl J Med, 1/10/2009
• The Role of RAS Modification for Primary and Secondary Stroke Prevention  
  Fintel DJ, Postgraduate Medicine, 1/1/2009
• The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience  
  Saab PG, Bang H, Williams RB, Powell LH, Schneiderman N, Thoresen C, Burg M, Keefe F; ENRICHD Investigators, J Psychosom Res, 1/1/2009
• Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients  
  Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators, New England Journal of Medicine, 1/1/2008
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein  
  Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto Jr AM , Kastelein JJ, Koenig W, Libby P, Lorensatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Gl..., New England Journal of Medicine, 1/1/2008
• Multiple myeloma presenting with high output heart failure and improving with anti-angiogensis therapy: a case series and review of the literature  
  Robin J, Fintel DJ, Pikovskaya O, Flaherty J, Cilley, Davidson C, J Med Case Rep, 1/1/2008
• Reduced mortality rates after Intensive Statin Therapy in managed-care patients  
  Fintel DJ, Joyce A, Mackell J, Graff J, Kuntze E. Ollendorf DA, Value in Health, 1/1/2007
• Cardiologists use Pulmonary Artery Catheter Information to make Homogenous Treatment Decisions  
  Jain M, Upadhyay D, Balagani R, Jovanovic B, Fintel D, Journal of Intensive Care Medicine, 1/1/2007
• Insurance coverage and care of patient with non-ST-segment elevation acute coronary syndromes  
  Calvin JE, Roe MT, Chen AY, Mehta RH, Brogan GX Jr, Delong ER, Fintel DJ, Gibler WB, Ohman EM, Smith SC Jr, Peterson ED, Annals of Internal Medicine, 1/1/2006
• Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative  
  Mehta RH, Roe Mt, Chen Ay, Lytle BL, Pollack CV Jr, Brindis RG, Smith SC Jr, Harrington RA, Fintel DJ, Fraulo ES, Califf RM, Gibler WB, Ohman Em, Peterson ED, Archives of Internal Medicine, 1/1/2006
• Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge  
  Tricoci P, Roe MT, Mulgund J, Newby LK, Smith SC Jr, Pollack CV Jr, Fintel DJ, Cannon CP, Bhatt DL, Gibler WB, Ohman EM, Peterson ED, Harrington RA, Archives of Internal Medicine, 1/1/2006
• The use of enoxaparin in emergency department protocols for early invasive approaches to managing chest pain patients  
  Fintel DJ, Invasive Cardiology Clinical Case Update, 1/1/2003
• Dosing considerations and monitoring of low molecular weight heparins and glycoprotein IIb/IIIa antagonists in patients with renal insufficiency  
  Rammohan C, Fintel DJ, Current Cardiology Reports, 1/1/2003
• Post-cardiac catheterization access site complications and low-molecular-weight heparin following cardiac catheterization  
  MacDonald LA, Meyers S, Bennett CL, Fintel DJ, Grosshans N, Syego R, Davidson CJ, J Invas Cardiol, 1/1/2003
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction  
  Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, for the Eplerenone Post-Acute Myocardial Infarction Heart Failure..., N Eng J Med, 1/1/2003
• Join now to see all

Books/Book Chapters

• Antithrombotic Therapy 
  Becker RC, Fintel DJ, Green DProfessional Communications, Inc.Edition 5th,2011
• Antithrombotic Therapy 
  Chapter: Fibrinolytic Agents. 
  Page 65 - 82Fintel DJEditors: Becker RC, Fintel DJ, Green D.Professional Communications, Inc., West Islip, NYEdition 5th,2011
• Antithrombotic Therapy 
  Chapter: Acute Myocardial Infarction. 
  Page 275 - 306Fintel DJEditors: Becker RC, Fintel DJ, Green D.Professional Communications, Inc., West Islip, NYEdition 5th,2011
• Antithrombotic Therapy 
  Chapter: Atrial Fibrillation. 
  Page 343 - 364Fintel DJEditors: Becker RC, Fintel DJ, Green D.Professional Communications, Inc., West Islip, NYEdition 5th,2011
• General Thoracic Surgery 
  Chapter: Preoperative cardiac evaluation of the thoracic surgical patient. 
  Page 339 - 347Robin J, Fintel DEditors: Shields TW, LoCicero J III, Reed CE, Feins RH.Wolters Kluwer Health/Lippincott William & WilkinsEdition 7th,2009
• Antithrombotic Therapy 
  Becker RC, Fintel DJ, Green DProfessional Communications, Inc.Edition 4th,2006
• Conn's Current Therapy 
  Chapter: Management of Atrial Fibrillation. 
  Page 340 - 344Brodsky AM, Fintel DJEditors: Rakel Re, Bope.W B Saunders2005
• Antithrombotic Therapy 
  Chapter: Atrial Fibrillation, Fibrinolytic Agents, and Acute Myocardial Infarction. In: Antithrombotic Therapy. 
  Fintel Dan JEditors: Becker LC, Fintel DJ, Green D.Professional Communications, Inc.Edition 3rd,2004
• Conn's Current Therapy 
  Chapter: Management of Unstable Angina. 
  Page 295 - 300Brodsky AM, Fintel DJEditors: Rakel RE, Bope ET.W B Saunders2004
• General Thoracic Surgery 
  Chapter: Preoperative cardiac evaluation of the thoracic surgery patient. 
  Page 1 - 209Rudin A, Fintel DJEdition 6th,2004
• The Physicians' Guide to Preventing Strokes and Lowering Health Risks in Patients with Atrial Fibrillation 
  Fintel DJ, Hoffmann CNorthwestern University Medical School and The Illinois Academy of Family Physicians, Chicago2000
• Antithrombotic Therapy 
  Chapter: Atrial Fibrillation, Fibrinolytic Agents, and Acute Myocardial Infarction. 
  Fintel Dan JEditors: Becker LC, Fintel DJ, Green D.Professional Communications, Inc.2000
• The Physicians' Guide to Preventing Strokes and Lowering Health Risks in Patients with Atrial Fibrillation 
  Fintel DJ, Hoffmann CNorthwestern University Medical School and The Illinois Academy of Family Physicians, Chicago1997
• Chest Surgery Clinics of North America 
  Chapter: Cardiac evaluation of the thoracic surgical patient. 
  Page 587 - 598Fintel D, Ali MEditors: LoCicero J.W.B. Saunders Co.1992
• Handbook of Critical Care Procedures And Therapies 
  Chapter: Pulmonary artery catheterization. 
  Page 28 - 46Isaacs DL, Fintel DJEditors: Cane R, Davison R, Albrink MH.Mosby Year Book1992
• Case Studies In Critical Care Medicine 
  Chapter: Acute myocardial ischemia. 
  Page 281 - 298Fintel DJ, Kaplan KEditors: Cane R, Shapiro B, Davison R.Year Book Medical Publishers, Inc.1990
• Nonpharmacologic Management of Cardiac Arrhythmias 
  Chapter: Exercise testing and cardiac arrhythmias. 
  Page 28 - 35Fintel DJ, Platia EVEditors: Platia EV.JB Lippincott Co.1986
• Unstable Angina: A Clinical Approach 
  Chapter: Nuclear imaging. 
  Page 395 - 416Fintel DJ, Becker LCEditors: Plotnick GD.Futura Publishing Co., Inc.1985
• Join now to see all

Abstracts/Posters

• Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardi...
  Alexander D, Ou F, Roe MT, Pollack CV Jr, Ohman EM, Cannon CP, Gibler WB, Fintel DJ, Peterson ED, Brown DL, Am Heart J, 1/1/2008
• Moderate hypothermia for anoxic encephalopathy after in-hospital and out-of-hospital cardiac arrest.
  Bernstein, RA, Dewan K, Naidech A, Bergman D, Oakley R, Garrett J, Fintel D, Alberts, M, European Stroke Conference, Glasgow, 1/1/2007
• The impact of pay for performance (P4P) on Quality of Care in Acute Coronary Syndromes: Initial External Evaluation of the Center for Medicare and Medicaid Services P4...
  Glickman SW, Mulgund J, Lytle BL, Rumsfeld JS, Roe MT, Gibler WB, Ohman EM, Fintel D, Schulman KA, Peterson ED, American Heart Association Conference, 1/1/2006
• The Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE quality improvement initiative.
  Meine TJ, Roe MT, Chen AY, Patel MR, Washam JB, Smith SC, Brown DF, Fintel D, Peacock, R, Gibler, WB, Peterson, ED, Am Heart J, 1/1/2005
• Impact of statin therapy intensity on all-cause mortality following cardiovascular hospitalization in a managed care population.
  Fintel DJ, Joyce AT, Mackell JA, Graff JS, Kuntze EE, Ollendorf DA, 6th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke of the American Heart Association, 1/1/2005
• Changing practice non non-ST-segment elevation acute coronary syndromes: Trends from the CRUSADE Quality Improvement Initiative from 2002 to 2004.
  Mehta RH, Roe Mt, Chen AY, Polack CV Jr, Brindis RG, Ohman EM, Gibler WB, Fintel D, Fraulo ES, Peterson ED, American Heart Association Scientific Sessions, 1/1/2005
• Higher mortality and less evidence-based therapies among medicaid-insured patients with high-risk ACS: Results from CRUSADE.
  Calvin, JE, Roe MT, Chen A, Brogan GX, DeLong ER, Gibler WB, Ohman EM, Fintel D, Smith SC, Peterson ED, JACC, 1/1/2004
• Suboptimal care non-ST-Segment elevation acute coronary syndrome patient presenting with congestive heart failure is associated with higher mortality.
  Goswami R, Chen AY, Riba AL, Fintel D, Gibler B, Circulation, 1/1/2004
• Underutilization of Clopidogrel at discharge in patients with non-ST-segment elevation acute coronary syndrome: Overlooking patient who do not undergo percutaneous cor...
  Tricoci P, Roe MT, Mulgund J, Pollack CV, Fintel D, Smith S, Gibler B, Circulation, 1/1/2004
• Variability in treatment responses using pulmonary artery catheter (PAC) and echocardiographic (echo) data among members of the American College of Cardiology.
  Laskaris E, Upadhyay D, Fintel D, Jain M, Am J Resp Crit Care Med, 1/1/2001
• Myocardial infarction during the first 72 hours of hospitalization is a predictor of late-term mortality in patients presenting with non-ST-segment acute coronary synd...
  Fintel DJ, Greenberg S, Lorenz TJ, Kitt MM, JACC, 1/1/2000
• Low-risk patients undergoing evaluation of acute chest pain do not benefit from heart rhythm monitoring.
  Tomasian DA, Hendel RC, Davison R, Hellstedt L, Fintel DJ, JACC, 1/1/2000
• Cycle length dependency of power spectrum.
  Monir G, Fintel DJ, Weiss JS, Zhang F, Nader-Sahyouni X, Rosenthal J, J Am Coll Cardiol, 1/1/1993
• Improvement in clinical outcomes of coronary angioplasty by treatment with the GPIIb/IIIa inhibitor chimeric 7E3: multivariable of the EPIC study.
  Tcheng JE, Topol EJ, Kleiman NS, Ellis SG, Navetta FI, Fintel DJ, Weisman HF, Anderson K, Wang AL, Miller JA, Sigmon KN, Califf RM, and the EPIC Investigators, Circulation, 1/1/1993
• Diagnostic accuracy of Tc-99m tetrofosmin and thallium-201 as assessed by receiver operating characteristic (ROC) analysis.
  Hendel RC, Parker M, Fintel DJ, Tetrofosmin Study Group, Circulation, 1/1/1993
• Improved sensitivity of tomographic Tl-201 imaging over conventional planar imaging following dipyridamole infusion.
  Mendelson MA, Spies SM, Spies WG, Stevens K, Abi-Mansour P, Fintel DJ, Am J Cardiol, 1/1/1992
• Heart rate variability: Focus on defined cycle lengths.
  Monir G, Fintel D, Yarnold P, Weiss J, Sahyouni N, Singer D, J Am Coll Cardiol, 1/1/1992
• Survival post-sudden cardiac death: Predictive value of heart rate variability vs. inducibility.
  Ahmed M, Fintel D, Zhang F, Sahyouni N, Weiss J, Bernauer T, Singer D, J Am Coll Cardiol, 1/1/1992
• Cycle length dependence of heart rate variability.
  Monir G, Fintel D, Yarnold P, Weiss J, Sahyouni N, Singer D, J Am Coll Cardiol, 1/1/1992
• Long term reproducibility of heart rate variability.
  Monir G, Fintel D, Weiss J, Zhang F, Bernauer T, Sahyouni N, Singer D, J Am Coll Cardiol, 1/1/1992
• Drug eruptions and rises in serum levels of streptokinase (SK) antibodies after infusions of anisoylated plasminogen streptokinase complex (APSAC).
  Dykewicz MS, Yazdi NK, Rutledge JL, Davison R, Fintel DJ, J Allergy Clin Immun, 1/1/1992
• Late potentials in ventricular fibrillation: improved detection by visual reanalysis.
  Fintel DJ, Huang S, Kim K, Abi-Mansour P, Schaad J, Weiss J, Reddy S, Singer D, J Am Coll Cardiol, 1/1/1991
• Improvement in autonomic activity after percutaneous transluminal coronary angioplasty: Assessment by heart rate variability.
  Larkin T, Fintel DJ, Meyers S, Moushmoush B, Cochran C, Niemyski P, Schaad J, Weiss J, Huang S, Singer D, J Am Coll Cardiol, 1/1/1991
• A double-blind, randomized comparison of anistreplase and alteplase in acute myocardial infarction: coronary patency results from the Team-3 Study.
  Anderson JL, Sorensen SG, Karagounis L, Browne KF, Shah PK, Morris DC, Fintel DJ, Mueller HS, Ross AM, J Am Coll Cardiol, 1/1/1991
• A dose response study of intravenous diltiazem for the treatment of atrial fibrillation and flutter.
  Goldenberg IF, Kleiger RE, Dias VC, Fintel DJ, Salerno D, Ellenbogen KA, Grey R, Vaughn L, Schroeder J, J Am Coll Cardiol, 1/1/1991
• Join now to see all

Other

• Updates on acute coronary syndromes. New insights on the need for glycoprotein (GP) IIb-IIIa inhibitor therapy. 
  Fintel DJ, Proceedings from the 51st Annual Scientific Session of the ACC, 17-20 March, 2002, Atlanta, GA; Heal
  1/1/2002
• Updates on acute coronary syndromes. Recent advances in glycoprotein (GP) IIb-IIIa inhibition: The clinical implications. 
  Fintel DJ, Proceedings from the 74th Annual Scientific Sessions of the AHA, 11-14 November, 2001, Anaheim, CA;
  1/1/2002
• Thrombolysis and beta-blockade in acute myocardial infarction. 
  Fintel DJ, Practical Cardiology
  1/1/1989
• Lessons from the heart: benefits from watchful waiting. 
  Fintel DJ, Chicago Medicine
  1/1/1989
• Treating hypercholesterolemia: crucial interventions or oversold "myth"? 
  Fintel DJ, Preventive Cardiology
  1/1/1989
• Join now to see all